Breast Cancer Center of Excellence
Abstract
Breast cancer is the second leading cause of cancer death in women in the United States. The Readiness and Lethality of the Total Force is based in large part on personnel health. Nearly 20% of the active-duty force is now female, and breast cancer is the number one cancer in active-duty women, far surpassing all other causes of cancer in this population. The Breast Cancer CoE utilizes a multidisciplinary approach for researching breast diseases and breast cancer focused on the military at-risk active-duty population in order to enhance Readiness of The Total Force. This multidisciplinary model integrates prevention, screening, early diagnosis, treatment and continuing care, but the project is further unique in the incorporation of advances in risk reduction, biomedical informatics, tissue banking and translational research. The project is based on a Discovery Science paradigm, leveraging high-throughput molecular biology technology and our unique clinically and pathologically well-characterized tissue repository with advances in biomedical informatics leading to hypothesis-generating discoveries that are then tested in hypothesis-driven experiments. In addition to the primary achievement of research objectives, the program educates Federal employees as a benefit to the public they serve through Federal service, through support to civil authorities, and in non-Federal professional and academic collaborations.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2024
- Source ID
- 8c52fa463533568806423fa290949ae9